"Onco-tese": Testicular sperm extraction in azoospermic cancer patients before chemotherapy - New guidelines?

Urology

Volumn 61, Issue 2, 2003, Pages 421-425

  Schrader, Mark ^a   Muller M ^b   Sofikitis, N ^b   Straub, B ^b   Krause, H ^b   Schostak, M ^b   Miller, K ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYTOSTATIC AGENT;

ARTICLE; AZOOSPERMIA; CANCER CHEMOTHERAPY; CANCER PATIENT; CLINICAL ARTICLE; CONTROLLED STUDY; CRYOPRESERVATION; FERTILITY; GERM CELL TUMOR; HISTOLOGY; HUMAN; LYMPHOMA; MALE; MALE INFERTILITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; SERTOLI CELL; SPERM PRESERVATION; SPERMATOZOON; TESTICULAR SPERM EXTRACTION; TESTIS BIOPSY; WOUND HEALING;

EID: 0037319307     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(02)02264-1     Document Type: Article

References (26)

1. Souchon R., Krege S., Schmoll H.J., et al. Interdisciplinary consensus on diagnosis and therapy of testicular tumors results of an update conference based on evidence-based medicine . Strahlenther Onkol. 176:2000;388-405.
2. Larson R.A. Recent clinical trials in acute lymphocytic leukemia by the Cancer and Leukemia Group B. Hematol Oncol Clin North Am. 14:2000;1367-1379.
3. Petersen P.M., Giwercman A., Skakkebaek N.E., et al. Gonadal function in men with testicular cancer. Semin Oncol. 25:1998;224-233.
4. Swerdlow A.J., Jacobs P.A., Marks A., et al. Fertility, reproductive outcomes, and health of offspring, of patients treated for Hodgkin's disease an investigation including chromosome examinations . Br J Cancer. 74:1996;291-296.
5. Schrader M., Muller M., Straub B., et al. The impact of chemotherapy on male fertility a survey of the biologic basis and clinical aspects . Reprod Toxicol. 15:2001;611-617.
6. Chan P.T., Palermo G.D., Veeck L.L., et al. Testicular sperm extraction combined with intracytoplasmic sperm injection in the treatment of men with persistent azoospermia postchemotherapy. Cancer. 92:2001;1632-1637.
7. Skakkebaek N.E. Possible carcinoma-in-situ of the testis. Lancet. 2:1972;516-517.
8. Amer M., Haggar S.E., Moustafa T., et al. Testicular sperm extraction impact of testicular histology on outcome, number of biopsies to be performed and optimal time for repetition . Hum Reprod. 14:1999;3030-3034.
9. Ostad M., Liotta D., Ye Z., et al. Testicular sperm extraction for nonobstructive azoospermia results of a multibiopsy approach with optimized tissue dispersion . Urology. 52:1998;692-696.
10. Schulze W., Thoms F., Knuth U.A. Testicular sperm extraction comprehensive analysis with simultaneously performed histology in 1418 biopsies from 766 subfertile men . Hum Reprod. 14:(suppl 1):1999;82-96.
11. Johnsen S.G. Testicular biopsy score count - a method for registration of spermatogenesis in human testes normal values and results in 335 hypogonadal males . Hormones. 1:1970;2-25.
12. DeKretser D.M., Holstein A.F. Testicular biopsy and abnormal germ cells. Hafez E.S. Human Semen and Fertility Regulation in Men. 1976;332-343 Mosby, St. Louis.
13. Bokemeyer C., Berger C.C., Kuczyk M.A., et al. Evaluation of long-term toxicity after chemotherapy for testicular cancer. J Clin Oncol. 14:1996;2923-2932.
14. van Steirteghem A. Twenty years of in vitro fertilization realization and questions for the future . Verh K Acad Geneeskd Belg. 63:2001;193-241.
15. Tal R., Botchan A., Hauser R., et al. Follow-up of sperm concentration and motility in patients with lymphoma. Hum Reprod. 15:2000;1985-1988.
16. Morrish D.W., Venner P.M., Siy O., et al. Mechanisms of endocrine dysfunction in patients with testicular cancer. J Natl Cancer Inst. 82:1990;412-418.
17. Petersen P.M., Giwercman A., Hansen S.W., et al. Impaired testicular function in patients with carcinoma-in-situ of the testis. J Clin Oncol. 17:1999;173-179.
18. Hayashi T., Arai G., Hyochi N., et al. Suppression of spermatogenesis in ipsilateral and contralateral testicular tissues in patients with seminoma by human chorionic gonadotropin beta subunit. Urology. 58:2001;251-257.
19. Nakazumi H., Sasano H., Maehara I., et al. Estrogen metabolism and impaired spermatogenesis in germ cell tumors of the testis. J Clin Endocrinol Metab. 81:1996;1289-1295.
20. Petersen P.M., Hansen S.W., Giwercman A., et al. Dose-dependent impairment of testicular function in patients treated with cisplatin-based chemotherapy for germ cell cancer. Ann Oncol. 5:1994;355-358.
21. Meistrich M.L., Wilson G., Ye W.S., et al. Hormonal protection from procarbazine-induced testicular damage is selective for survival and recovery of stem spermatogonia. Cancer Res. 54:1994;1027-1034.
22. Kangasniemi M., Wilson G., Huhtaniemi I., et al. Protection against procarbazine-induced testicular damage by GnRH-agonist and antiandrogen treatment in the rat. Endocrinology. 136:1995;3677-3680.
23. Meistrich M.L. Hormonal stimulation of the recovery of spermatogenesis following chemo- or radiotherapy review article . APMIS. 106:1998;37-46.
24. Byrne J. Long-term genetic and reproductive effects of ionizing radiation and chemotherapeutic agents on cancer patients and their offspring. Teratology. 59:1999;210-215.
25. Trasler J.M., Hales B.F., Robaire B. Paternal cyclophosphamide treatment of rats causes fetal loss and malformations without affecting male fertility. Nature. 316:1985;144-146.
26. Sega G.A. Adducts in sperm protamine and DNA vs. mutation frequency. Prog Clin Biol Res. 372:1991;521-530.